TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6434285

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fluid and electrolyte replacement (without TPN)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 48
Study: 31769496

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.5 mg
Number of subjects: 4712

Group type: EXPERIMENTAL
Intervention: Semaglutide 1.0 mg
Number of subjects: 4712

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4712

Group type: COMPARATOR
Intervention: Active comparators (sitagliptin 100 mg, exenatide extended release 2.0 mg, insulin glargine 100IU/ml, dulaglutide 0.75 or 1.5 mg)
Number of subjects: 4712
Study: 31136288

Group type: EXPERIMENTAL
Intervention: Early intensive blood pressure lowering
Number of subjects: 2598

Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure lowering
Number of subjects: 2598

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 2598
Study: 28404155

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 1057
Study: 26132642

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 34
Study: 23782429

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (300,000 IU cholecalciferol in oily solution administered seven days pre-operatively)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 80
Study: 21665114

Group type: EXPERIMENTAL
Intervention: Topical cetylated fatty ester complex (CFEC) cream application plus physical therapy (CF‐PT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo cream application plus physical therapy (PL‐PT)
Number of subjects: 72
Study: 19247271

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) 3 days/week
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sedentary (SED)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (RT and SED)
Number of subjects: 16
Study: 16946605

Group type: EXPERIMENTAL
Intervention: Sealing proximal lesions with 1 of 2 resins (test group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no sealing, only flossing)
Number of subjects: 72
Study: 12973509

Group type: EXPERIMENTAL
Intervention: Pre-thickened infant formula (Nan AR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional homemade formula with starch
Number of subjects: 100
Study: 10638577

Group type: EXPERIMENTAL
Intervention: Slow-release 5-ASA suppositories (Pentasa 1 g/day)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional 5-ASA suppositories (Rowasa 0.5 g b.i.d.)
Number of subjects: 251
Study: 8989955

Group type: EXPERIMENTAL
Intervention: Triple semicircular canal occlusion (TCO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Labyrinthectomy
Number of subjects: 8
Study: 1312757

Group type: EXPERIMENTAL
Intervention: Collagenase (n = 50/400 ABC‐U/disc)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chymopapain (n = 50/4000 I.U.)
Number of subjects: 100
Study: 3850489

Group type: EXPERIMENTAL
Intervention: Collaborative goal-setting group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provider goal-setting group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30716669

Group type: EXPERIMENTAL
Intervention: Postural sway in cancer survivors
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Self-reported neuropathy in cancer survivors
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Self-reported falls in cancer survivors
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Mediolateral sway in cancer survivors with neuropathy
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Resultant/AP sway frequency in cancer survivors with neuropathy
Number of subjects: 434

Group type: COMPARATOR
Intervention: Postural sway in healthy control subjects
Number of subjects: 434
Study: 29311038

Group type: EXPERIMENTAL
Intervention: Enhanced Stop Light Diet
Number of subjects: 146

Group type: COMPARATOR
Intervention: Conventional Diet
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 146
Study: 26232779

Group type: EXPERIMENTAL
Intervention: 150 ml/dinner dry red wine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 150 ml/dinner dry red wine (among fast ethanol metabolizers)
Number of subjects: 54
Study: 24447498

Group type: EXPERIMENTAL
Intervention: Lower-dose tranexamic acid regimen (loading dose of 10 mg/kg, maintenance dose of 2 mg/kg/h, pump prime dose of 40 mg)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Higher-dose tranexamic acid regimen (loading dose of 30 mg/kg, maintenance dose of 16 mg/kg/h, pump prime dose of 2 mg/kg)
Number of subjects: 175
Study: 22158139

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) during low-intensity resistance exercise (16 minutes, 85 Hz)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control condition (low-intensity resistance exercise without WB-EMS)
Number of subjects: 19
Study: 20380656

Group type: EXPERIMENTAL
Intervention: Dutogliptin 400 mg
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Dutogliptin 200 mg
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423
Study: 17286343

Group type: EXPERIMENTAL
Intervention: Economic Form 90
Number of subjects: 0
Study: 16117574

Group type: EXPERIMENTAL
Intervention: Psychological therapy (PRP trial)
Number of subjects: 100
Study: 12577349

Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and western medicine (TCM-WM) including cardiac diuretics, vasodilative agents, taurine, coenzyme Q10, antiarrhythmics, beta blockers, and Chinese herbal preparations such as Astragalus membranaceus and Shengmai injection.
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional western medicine alone (control group).
Number of subjects: 320
Study: 9713095

Group type: EXPERIMENTAL
Intervention: Continuous treatment (Group 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Discontinuous treatment (Group 2)
Number of subjects: 36
Study: 8029650

Group type: EXPERIMENTAL
Intervention: Buffered lignocaine with adrenaline (pH 7.1‐7.3)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lignocaine with adrenaline (unbuffered)
Number of subjects: 31
Study: 2740841

Group type: EXPERIMENTAL
Intervention: Sucralfate in tablets
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sucralfate in suspension
Number of subjects: 66
Study: 31374049

Group type: EXPERIMENTAL
Intervention: Xiaoai Jiedu Decoction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xiaoai Jiedu Decoction mimetic agent
Number of subjects: 0
Study: 28758519

Group type: EXPERIMENTAL
Intervention: 8-week perturbed treadmill intervention (n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (n = 22) training on identical treadmill without perturbations
Number of subjects: 43
Study: 25458464

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) treatment (2400 mg/day divided into two doses) for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no NAC treatment)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) treatment
Number of subjects: 21
Study: 23620932

Group type: EXPERIMENTAL
Intervention: Acupuncture at Neiguan (PC 6) and Taichong (LR 3)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional acupoints (Yanglingquan (GB 34), Yinlingquan (SP 9), Neixiyan (EX‐LE 4), Dubi (ST 35), Zusanli (ST 36))
Number of subjects: 44
Study: 21478764

Group type: COMPARATOR
Intervention: 0% body weight assistance (BWA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10% body weight assistance (BWA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20% body weight assistance (BWA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 30% body weight assistance (BWA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 40% body weight assistance (BWA)
Number of subjects: 18
Study: 18239389

Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiographic examination
Number of subjects: 137

Group type: COMPARATOR
Intervention: Candesartan (angiotensin II receptor antagonist)
Number of subjects: 137
Study: 16820564

Group type: EXPERIMENTAL
Intervention: AMI cell infusion
Number of subjects: 96

Group type: COMPARATOR
Intervention: AMI control
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: OMI cell infusion
Number of subjects: 96

Group type: COMPARATOR
Intervention: OMI control
Number of subjects: 96
Study: 12752749

Group type: COMPARATOR
Intervention: Sumatriptan (tablet and nasal spray) and naratriptan (tablet)
Number of subjects: 1932
Study: 10828475

Group type: EXPERIMENTAL
Intervention: SCFA enemas
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo enemas
Number of subjects: 32
Study: 9531736

Group type: EXPERIMENTAL
Intervention: Transdermal ketoprofen 30 mg over the proposed surgical area twice (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo patch (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transdermal ketoprofen 30 mg over right thigh twice (Group 3)
Number of subjects: 60
Study: 8196571

Group type: EXPERIMENTAL
Intervention: Empirical antimicrobial therapy
Number of subjects: 1573

Group type: EXPERIMENTAL
Intervention: Early systemic antifungal treatment
Number of subjects: 1573
Study: 3065085

Group type: EXPERIMENTAL
Intervention: Tamoxifen (30 mg/day) + bromocriptine (5 mg/day)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Tamoxifen + placebo
Number of subjects: 171
Study: 29767330

Group type: EXPERIMENTAL
Intervention: 6-Fr Glidesheath Slender
Number of subjects: 200

Group type: COMPARATOR
Intervention: 6-Fr standard sheath
Number of subjects: 200
Study: 30993313

Group type: EXPERIMENTAL
Intervention: Metformin XL (2000 mg daily for 12 months)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 29979390

Group type: EXPERIMENTAL
Intervention: Fotemustine at 120 mg/m biweekly
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fotemustine at 140 mg/m biweekly
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard weekly schedule at 80 to 100 mg/m (not directly tested in this trial)
Number of subjects: 37
Study: 27123229

Group type: EXPERIMENTAL
Intervention: Desmopressin 120 micrograms daily for 2 months, then 60 micrograms daily for 2 months, then 60 micrograms every 2 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oxybutynin 5 mg twice a day for 6 months
Number of subjects: 66
Study: 24660739

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (CEUS) using Sonazoid (perflubutane)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Unenhanced ultrasound
Number of subjects: 127

Group type: COMPARATOR
Intervention: Contrast-enhanced MRI
Number of subjects: 127
Study: 22699138

Group type: EXPERIMENTAL
Intervention: Increased physical activity for 1 week
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Reduced physical activity for 1 week
Number of subjects: 111

Group type: COMPARATOR
Intervention: Depressed participants
Number of subjects: 111

Group type: COMPARATOR
Intervention: Persons with SSI‐8
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Higher general fitness
Number of subjects: 111
Study: 19542997

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 56

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 56
Study: 17305893

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 6 hours later (n=225)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 36-48 hours later (n=225)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 6 hours later
Number of subjects: 450

Group type: COMPARATOR
Intervention: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 36-48 hours later
Number of subjects: 450
Study: 15341547

Group type: EXPERIMENTAL
Intervention: Cooperative Health Care Clinic (CHCC) group outpatient model
Number of subjects: 294
Study: 12137213

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 9864835

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 0.01 mg/kg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 0.05 mg/kg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 0.1 mg/kg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 0.5 mg/kg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 20 mg biweekly
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: i.v. TNFR55-IgG1 50 mg monthly after loading dose of 100 mg
Number of subjects: 218

Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 218
Study: 7890253

Group type: EXPERIMENTAL
Intervention: Ethanol (1 ml/kg, 95% ethanol)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isocaloric carbohydrate drink
Number of subjects: 7
Study: 2197536

Group type: EXPERIMENTAL
Intervention: Inhalation of 300 mg of pentamidine every 28 days
Number of subjects: 160

Group type: COMPARATOR
Intervention: Inhalation of placebo (300 mg of Na isethionate) every 28 days
Number of subjects: 160
Study: 343479

Group type: EXPERIMENTAL
Intervention: Extradural injection of 2 ml (80 mg) methyl prednisolone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group received 2 ml normal saline solution
Number of subjects: 51
Study: 7244394

Group type: EXPERIMENTAL
Intervention: Obesity (O)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chronic renal failure under hemodialysis (H)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pneumonia (P)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal personnel (N)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Interstitial lung disease (CILD)
Number of subjects: 36
Study: 31269394

Group type: EXPERIMENTAL
Intervention: CT3RGDcT3AYJCT3 (J: D‐Leu)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CT3RGDcT3AYaCT3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CT3RGDcT3AWGCT3
Number of subjects: 0

Group type: COMPARATOR
Intervention: knottin-RGD
Number of subjects: 0
Study: 27810148

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided extrathoracic sub-paraspinal block
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 26340540

Group type: EXPERIMENTAL
Intervention: Zephyr® EBV treatment in upper lobe (n=45)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Zephyr® EBV treatment in lower lobe (n=15)
Number of subjects: 331
Study: 24042256

Group type: EXPERIMENTAL
Intervention: Aspirin (81-100 mg daily)
Number of subjects: 2539

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 2539
Study: 21832272

Group type: EXPERIMENTAL
Intervention: Selegiline for cigarette smoking cessation
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 280
Study: 19848195

Group type: EXPERIMENTAL
Intervention: Qingxuan Tiaoya Recipe (QXTYR) + perindopril tablet
Number of subjects: 87

Group type: COMPARATOR
Intervention: Simulator of QXTYR + perindopril tablet
Number of subjects: 87
Study: 17563125

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg FDT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Desloratadine 5 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15062907

Group type: EXPERIMENTAL
Intervention: Patient Information Leaflet (PIL)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 317
Study: 12165594

Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia (target temperature of 34.5 degrees C for 72 hours)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia
Number of subjects: 19
Study: 10091410

Group type: EXPERIMENTAL
Intervention: Group A: Peripheral blood stem cells (PBSC) collected after induction and consolidation chemotherapy, followed by ABSCT immediately thereafter.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group B: PBSC collected after consolidation alone, followed by intermediate dose cytarabine (Ara‐C 1 g/m2/12 h x3 days) and mitoxantrone (12 mg/m2/d x3 days) as early intensification before ABSCT.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 50

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 7844085

Group type: EXPERIMENTAL
Intervention: Combination of salbutamol plus beclomethasone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Salbutamol alone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Beclomethasone alone
Number of subjects: 22
Study: 2347981

Group type: EXPERIMENTAL
Intervention: Social skills training (8 sessions + 4 booster sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study: 624427

Group type: EXPERIMENTAL
Intervention: Low-dose cortisone
Number of subjects: 38
Study: 31485929

Group type: COMPARATOR
Intervention: Ultrasound-guided transversus abdominis plane blocks (UTAP)
Number of subjects: 60
Study: 30587521

Group type: EXPERIMENTAL
Intervention: Linoleic acid solution
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Sweet (sucrose) solution
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Salty (NaCl) solution
Number of subjects: 46

Group type: COMPARATOR
Intervention: Paraffin oil mixture or water (control)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Five FFA solutions
Number of subjects: 46

Group type: COMPARATOR
Intervention: Paraffin emulsion (control)
Number of subjects: 46
Study: 26771291

Group type: EXPERIMENTAL
Intervention: Citalopram (8 weeks treatment)
Number of subjects: 70

Group type: COMPARATOR
Intervention: CBT-waitlisted subjects (control)
Number of subjects: 70
Study: 26033648

Group type: EXPERIMENTAL
Intervention: VAC (vacuum assisted closure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bogota bag
Number of subjects: 40
Study: 23787939

Group type: EXPERIMENTAL
Intervention: Early digit mobilization
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (usual home programmes)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 22115379

Group type: EXPERIMENTAL
Intervention: Solution Focused Therapy (SFT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy (PST)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 29
Study: 19380429

Group type: EXPERIMENTAL
Intervention: Youth HIV intervention plus a parental monitoring/communication/HIV education intervention
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Youth HIV intervention plus a parental goal-setting intervention
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Environmental protection intervention plus parental goal-setting intervention
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Focus on Youth in the Caribbean groups
Number of subjects: 1360
Study: 16892911

Group type: EXPERIMENTAL
Intervention: Vaccine efficacy against infection and disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonparametric kernel smoothing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Locally parametric penalized splines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fully parametric cubic linear splines
Number of subjects: 0
Study: 15572812

Group type: EXPERIMENTAL
Intervention: Terbutaline (250 mcg, 3 puffs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Salbutamol (100 mcg, 3 puffs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both Terbutaline and Salbutamol
Number of subjects: 60
Study: 12214823

Group type: EXPERIMENTAL
Intervention: Computerized version of the Tower of Hanoi puzzle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wooden version of the Tower of Hanoi puzzle
Number of subjects: 0
Study: 9633848

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy
Number of subjects: 0
Study: 8543621

Group type: EXPERIMENTAL
Intervention: 1% Uvitex 2B staining
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (10 patients without infection)
Number of subjects: 18
Study: 2153193

Group type: COMPARATOR
Intervention: CAV (cyclophosphamide, doxorubicin, and vincristine)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: CAVE (CAV plus etoposide)
Number of subjects: 231
Study: 348533

Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 29253068

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day for 1 year
Number of subjects: 742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 742
Study: 26484952

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 2 sessions per week for 8 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT) - additional sets
Number of subjects: 26
Study: 24955550

Group type: EXPERIMENTAL
Intervention: Saffron aqueous extract (SAE) 30 mg daily
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Crocin 30 mg daily
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 21948742

Group type: EXPERIMENTAL
Intervention: Asperger syndrome
Number of subjects: 32

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 32
Study: 20349863

Group type: EXPERIMENTAL
Intervention: Cemented metal-on-metal THA
Number of subjects: 195

Group type: COMPARATOR
Intervention: Metal-on-polyethylene THA
Number of subjects: 195
Study: 17091015

Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Anteromedial single-bundle ACL reconstruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Posterolateral single-bundle ACL reconstruction
Number of subjects: 60